220 related articles for article (PubMed ID: 35340200)
1. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd
Hayes HM; Angerosa J; Piers AT; White JD; Koleff J; Thurgood M; Moody J; Cheung MM; Pepe S
Oxid Med Cell Longev; 2022; 2022():5362115. PubMed ID: 35340200
[TBL] [Abstract][Full Text] [Related]
2. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
[TBL] [Abstract][Full Text] [Related]
3. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
4. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Cardiac Structure and Function of Conscious D2.B10-
De Giorgio D; Novelli D; Motta F; Cerrato M; Olivari D; Salama A; Fumagalli F; Latini R; Staszewsky L; Crippa L; Steinkühler C; Licandro SA
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511564
[TBL] [Abstract][Full Text] [Related]
6. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
[TBL] [Abstract][Full Text] [Related]
7. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic background on the dystrophic phenotype in mdx mice.
Coley WD; Bogdanik L; Vila MC; Yu Q; Van Der Meulen JH; Rayavarapu S; Novak JS; Nearing M; Quinn JL; Saunders A; Dolan C; Andrews W; Lammert C; Austin A; Partridge TA; Cox GA; Lutz C; Nagaraju K
Hum Mol Genet; 2016 Jan; 25(1):130-45. PubMed ID: 26566673
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
10. Early right ventricular fibrosis and reduction in biventricular cardiac reserve in the dystrophin-deficient mdx heart.
Meyers TA; Townsend D
Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H303-15. PubMed ID: 25485898
[TBL] [Abstract][Full Text] [Related]
11. AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy.
Bostick B; Shin JH; Yue Y; Wasala NB; Lai Y; Duan D
J Mol Cell Cardiol; 2012 Aug; 53(2):217-22. PubMed ID: 22587991
[TBL] [Abstract][Full Text] [Related]
12. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
Su X; Jin Y; Shen Y; Ju C; Cai J; Liu Y; Kim IM; Wang Y; Yu H; Weintraub NL; Jiang M; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):412-419. PubMed ID: 30155598
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Kim MJ; Bible KL; Regnier M; Adams ME; Froehner SC; Whitehead NP
Physiol Rep; 2019 Mar; 7(6):e14018. PubMed ID: 30912308
[TBL] [Abstract][Full Text] [Related]
14. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
[TBL] [Abstract][Full Text] [Related]
15. Intracellular calcium handling in ventricular myocytes from mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H846-55. PubMed ID: 17012353
[TBL] [Abstract][Full Text] [Related]
16. Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart.
Haffner V; Nourian Z; Boerman EM; Lambert MD; Hanft LM; Krenz M; Baines CP; Duan D; McDonald KS; Domeier TL
Am J Physiol Heart Circ Physiol; 2023 Nov; 325(5):H1168-H1177. PubMed ID: 37737731
[TBL] [Abstract][Full Text] [Related]
17. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1969-77. PubMed ID: 17573457
[TBL] [Abstract][Full Text] [Related]
18. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
19. Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging.
Li W; Liu W; Zhong J; Yu X
J Cardiovasc Magn Reson; 2009 Oct; 11(1):40. PubMed ID: 19849858
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Reutenauer J; Dorchies OM; Patthey-Vuadens O; Vuagniaux G; Ruegg UT
Br J Pharmacol; 2008 Oct; 155(4):574-84. PubMed ID: 18641676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]